These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 33336276

  • 21. Coincident Fluorescence-Burst Analysis of the Loading Yields of Exosome-Mimetic Nanovesicles with Fluorescently-Labeled Cargo Molecules.
    Sanaee M, Sandberg E, Ronquist KG, Morrell JM, Widengren J, Gallo K.
    Small; 2022 Mar; 18(12):e2106241. PubMed ID: 35084110
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Size Exclusion Chromatography: A Simple and Reliable Method for Exosome Purification.
    Lobb R, Möller A.
    Methods Mol Biol; 2017 Mar; 1660():105-110. PubMed ID: 28828651
    [Abstract] [Full Text] [Related]

  • 24. Integrated isolation and quantitative analysis of exosome shuttled proteins and nucleic acids using immunocapture approaches.
    Zarovni N, Corrado A, Guazzi P, Zocco D, Lari E, Radano G, Muhhina J, Fondelli C, Gavrilova J, Chiesi A.
    Methods; 2015 Oct 01; 87():46-58. PubMed ID: 26044649
    [Abstract] [Full Text] [Related]

  • 25. Exosome mimetics: a novel class of drug delivery systems.
    Kooijmans SA, Vader P, van Dommelen SM, van Solinge WW, Schiffelers RM.
    Int J Nanomedicine; 2012 Oct 01; 7():1525-41. PubMed ID: 22619510
    [Abstract] [Full Text] [Related]

  • 26. Pseudotyping exosomes for enhanced protein delivery in mammalian cells.
    Meyer C, Losacco J, Stickney Z, Li L, Marriott G, Lu B.
    Int J Nanomedicine; 2017 Oct 01; 12():3153-3170. PubMed ID: 28458537
    [Abstract] [Full Text] [Related]

  • 27. Exosome as a Novel Shuttle for Delivery of Therapeutics across Biological Barriers.
    Das CK, Jena BC, Banerjee I, Das S, Parekh A, Bhutia SK, Mandal M.
    Mol Pharm; 2019 Jan 07; 16(1):24-40. PubMed ID: 30513203
    [Abstract] [Full Text] [Related]

  • 28. Exosome: An Emerging Source of Biomarkers for Human Diseases.
    Xu L, Wu LF, Deng FY.
    Curr Mol Med; 2019 Jan 07; 19(6):387-394. PubMed ID: 31288712
    [Abstract] [Full Text] [Related]

  • 29. Purposing plant-derived exosomes-like nanovesicles for drug delivery: patents and literature review.
    Orefice NS, Di Raimo R, Mizzoni D, Logozzi M, Fais S.
    Expert Opin Ther Pat; 2023 Feb 07; 33(2):89-100. PubMed ID: 36947052
    [Abstract] [Full Text] [Related]

  • 30. Artificial exosomes for translational nanomedicine.
    Li YJ, Wu JY, Liu J, Xu W, Qiu X, Huang S, Hu XB, Xiang DX.
    J Nanobiotechnology; 2021 Aug 12; 19(1):242. PubMed ID: 34384440
    [Abstract] [Full Text] [Related]

  • 31. Microfluidic fabrication of cell-derived nanovesicles as endogenous RNA carriers.
    Jo W, Jeong D, Kim J, Cho S, Jang SC, Han C, Kang JY, Gho YS, Park J.
    Lab Chip; 2014 Apr 07; 14(7):1261-9. PubMed ID: 24493004
    [Abstract] [Full Text] [Related]

  • 32. Proteomic and Post-Translational Modification Profiling of Exosome-Mimetic Nanovesicles Compared to Exosomes.
    Nasiri Kenari A, Kastaniegaard K, Greening DW, Shambrook M, Stensballe A, Cheng L, Hill AF.
    Proteomics; 2019 Apr 07; 19(8):e1800161. PubMed ID: 30790448
    [Abstract] [Full Text] [Related]

  • 33. Exosomes as New Biomarkers and Drug Delivery Tools for the Prevention and Treatment of Various Diseases: Current Perspectives.
    Liu Q, Li S, Dupuy A, Mai HL, Sailliet N, Logé C, Robert JH, Brouard S.
    Int J Mol Sci; 2021 Jul 21; 22(15):. PubMed ID: 34360530
    [Abstract] [Full Text] [Related]

  • 34. Isolation of Exosomes and Microvesicles from Cell Culture Systems to Study Prion Transmission.
    Leblanc P, Arellano-Anaya ZE, Bernard E, Gallay L, Provansal M, Lehmann S, Schaeffer L, Raposo G, Vilette D.
    Methods Mol Biol; 2017 Jul 21; 1545():153-176. PubMed ID: 27943213
    [Abstract] [Full Text] [Related]

  • 35. Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis.
    Doyle LM, Wang MZ.
    Cells; 2019 Jul 15; 8(7):. PubMed ID: 31311206
    [Abstract] [Full Text] [Related]

  • 36. [Analysis and Control of in Vivo Kinetics of Exosomes for the Development of Exosome-based DDS].
    Takahashi Y, Nishikawa M, Takakura Y.
    Yakugaku Zasshi; 2016 Jul 15; 136(1):49-53. PubMed ID: 26725667
    [Abstract] [Full Text] [Related]

  • 37. Engineering of Exosomes: Steps Towards Green Production of Drug Delivery System.
    Sherif AY, Harisa GI, Alanazi FK, Youssof AME.
    Curr Drug Targets; 2019 Jul 15; 20(15):1537-1549. PubMed ID: 31309889
    [Abstract] [Full Text] [Related]

  • 38. Plant Exosome-like Nanovesicles: Emerging Therapeutics and Drug Delivery Nanoplatforms.
    Dad HA, Gu TW, Zhu AQ, Huang LQ, Peng LH.
    Mol Ther; 2021 Jan 06; 29(1):13-31. PubMed ID: 33278566
    [Abstract] [Full Text] [Related]

  • 39. Adipose stem cell-derived nanovesicles inhibit emphysema primarily via an FGF2-dependent pathway.
    Kim YS, Kim JY, Cho R, Shin DM, Lee SW, Oh YM.
    Exp Mol Med; 2017 Jan 13; 49(1):e284. PubMed ID: 28082743
    [Abstract] [Full Text] [Related]

  • 40. Exosome-like systems: Nanotechnology to overcome challenges for targeted cancer therapies.
    García-Fernández J, Fuente Freire M.
    Cancer Lett; 2023 May 01; 561():216151. PubMed ID: 37001751
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.